XML 13 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Jun. 30, 2019
Current assets:    
Cash $ 441,004 $ 34,371
Accounts receivable, net 134,517 218,145
Inventory, net 679,471 356,285
Loan receivables, current 1,365 85,533
Loan Receivable - related parties, current 122,535  
Other current assets 263,404 2,719,875
Right of use assets, current 270,363  
Total current assets 1,912,659 3,414,209
Equipment, net 499,047 476,585
Intangible Asset 9,800 11,200
Other assets 54,163 23,970
Loan Receivable - related parties, noncurrent 196,000  
Right of use asset 835,392
Advanced to Investments 18,000,000
Total Assets 3,507,062 21,925,965
Current liabilities:    
Note payable due to bank 25,982 25,982
Accounts payable and accrued liabilities 1,583,228 1,431,379
Customer deposits 466,337 287,789
Customer Overpayment 47,890 42,307
Unearned revenue 53,248 61,672
Other payable 691,801 420,450
Accrued interest 494,740 507,218
Accrued compensation and personnel related payables 35,361 24,528
Note Payable - Current 20,000 20,000
Notes payable - related parties - Current 15,427 18,000
Lease liability - Current 372,285
Loans payable, Current 319,314 214,585
Loans payable - related party - Current 35,943 30,000
Convertible notes payable, net - Current 1,740,122 1,046,909
Derivative liabilities 5,597,095 2,991,953
Warrants liabilities 79,910 24,658
Shares to be issued 101,577 100,000
Total current liabilities 11,680,260 7,247,431
Non-Current liabilities:    
Loan Payable 197,946  
Lease Liability 767,729
Total liabilities 12,645,935 7,247,431
Stockholders' deficiency:    
Preferred Stock, $0.001 Par Value, 10,000,000 Shares Authorized, 3,541,500 and 2,000,000 Shares Issued and Outstanding at June 30, 2020 and June 2019, respectively 3,542 2,000
Common Stock, $0.001 Par Value, 10,000,000,000 Shares Authorized, 1,763,277,230 and 697,608,570 Shares Issued and Outstanding at June 30, 2020 and 2019 1,763,278 697,610
Additional paid-in capital 57,307,767 61,038,875
Common Stock Subscribed 236,008  
Shares to Be Issued, Common Shares 29,000
Accumulated deficiency (68,438,332) (47,088,950)
Total stockholders' equity (deficiency) (9,127,737) 14,678,534
Non-Controlling Interest (11,136)
Total stockholders' deficiency (9,138,873) 14,678,534
Total liabilities and stockholders' equity (deficiency) $ 3,507,062 $ 21,925,965